{"id":"W3083454034","doi":"10.1093/ajhp/zxaa197","title":"Optimal sequencing strategies in the treatment of EGFR mutation–positive non–small cell lung cancer: Clinical benefits and cost-effectiveness","year":2020,"lang":"en","type":"review","venue":"American Journal of Health-System Pharmacy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Afatinib; Osimertinib; Medicine; Lung cancer; Erlotinib; Cost effectiveness; Oncology; Clinical trial; Epidermal growth factor receptor; Intensive care medicine; Cancer; Internal medicine; Risk analysis (engineering)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004682553,0.0008047812,0.001472879,0.0008855703,0.0001685446,0.001095627,0.0006662831,0.001118417,0.00472079],"category_scores_gemma":[0.01231798,0.0002498845,0.001938836,0.0005317458,0.0004638055,0.001337507,0.0006533344,0.001553483,0.0002708262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00166092,"about_ca_system_score_gemma":0.002306405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000914836,"about_ca_topic_score_gemma":0.001537233,"domain_scores_codex":[0.9969203,0.002110785,0.0002692259,0.0001620119,0.0004245471,0.0001132523],"domain_scores_gemma":[0.9946972,0.003763168,0.001007807,0.00006312412,0.0002097154,0.0002589469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01274199,0.001333397,0.005345978,0.00857543,0.00294687,0.0002298451,0.00009129973,0.09343415,0.001558303,0.009895396,0.004271506,0.8595758],"study_design_scores_gemma":[0.03779633,0.08485422,0.07569423,0.06119866,0.03730496,0.006181881,0.001504886,0.3385254,0.01425414,0.2215398,0.1205096,0.0006359394],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2211519,0.700615,0.03761169,0.02309531,0.001272561,0.001577302,0.0005512198,0.0001592105,0.01396581],"genre_scores_gemma":[0.8256148,0.1434681,0.02346751,0.004524513,0.0008830112,0.0006799548,0.0003887934,0.00003934588,0.0009339327],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00472079,"threshold_uncertainty_score":0.024764,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1028731177825195,"score_gpt":0.4878015661155438,"score_spread":0.3849284483330243,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}